首页 > 最新文献

Indian Journal of Medical Specialities最新文献

英文 中文
Clinical spectrum and outcome of guillain-barré syndrome with plasmapheresis 血浆置换术治疗格林-巴利综合征的临床特点及疗效
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_50_22
Safia Bano, Zomer Sardar, M. Ahmar, Sumayyah Liaquat, B. Shafiq, A. Numan
Context: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy and has several electrophysiological subtypes and clinical variants. Treatment is mainly supportive and immunotherapy is given to shorten the disease course. Aims: The aim of this study was to define the outcome of GBS with plasmapheresis and to determine its clinical spectrum. Materials and Methods: The prospective study was done at Mayo Hospital, Lahore, for 1 year from November 2020 to November 2021. The diagnosis of GBS was made on Brighton criteria for GBS. The outcome of therapy was assessed at 3 and 6 months, using the Medical Research Council Scale and Hughes Functional Grading Scale (HFGS). Results: A total of 50 patients were enrolled in the study. Twenty-seven (54%) were males and 23 (46%) were females. Seventeen (34%) had acute motor axonal neuropathy, 16 (32%) had acute motor and sensory axonal neuropathy, 15 (30%) had acute inflammatory demyelinating polyradiculoneuropathy, and 2 (4%) had Miller-Fisher syndrome. Plasmapheresis was done in all patients. HFGS score was assessed at discharge, at 3 months, and after 6 months of illness onset. The improvement in mean HFGS score was 2.79 ± 0.41 at 3 months and 1.94 ± 0.25 at 6 months of symptoms onset from the mean score of 3.46 ± 0.93 at the time of discharge from the hospital. Conclusion: Excellent outcome was observed after plasmapheresis. Majority of participants were able to walk without support at the 6-month follow-up. Plasmapheresis should be initiated early in the management of GBS where intravenous immunoglobulins are costly.
背景:格林-巴勒综合征(GBS)是一种急性炎症性神经病变,具有多种电生理亚型和临床变异。治疗以支持治疗为主,并给予免疫治疗以缩短病程。目的:本研究的目的是确定GBS合并血浆置换的结局,并确定其临床谱。材料和方法:前瞻性研究在拉合尔梅奥医院完成,为期1年,从2020年11月至2021年11月。根据布莱顿标准诊断GBS。使用医学研究委员会量表和休斯功能分级量表(HFGS)在3个月和6个月时评估治疗结果。结果:共有50例患者入组研究。男性27例(54%),女性23例(46%)。17例(34%)为急性运动轴索神经病,16例(32%)为急性运动和感觉轴索神经病,15例(30%)为急性炎性脱髓鞘性多根神经神经病,2例(4%)为米勒-费舍尔综合征。所有患者均行血浆置换。在出院时、发病3个月时和发病6个月后评估HFGS评分。症状出现3个月时HFGS平均评分为2.79±0.41,症状出现6个月时平均评分为1.94±0.25,而出院时平均评分为3.46±0.93。结论:血浆置换术后疗效良好。在6个月的随访中,大多数参与者能够在没有支持的情况下行走。在静脉注射免疫球蛋白费用昂贵的GBS治疗中,应尽早开始血浆置换。
{"title":"Clinical spectrum and outcome of guillain-barré syndrome with plasmapheresis","authors":"Safia Bano, Zomer Sardar, M. Ahmar, Sumayyah Liaquat, B. Shafiq, A. Numan","doi":"10.4103/injms.injms_50_22","DOIUrl":"https://doi.org/10.4103/injms.injms_50_22","url":null,"abstract":"Context: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy and has several electrophysiological subtypes and clinical variants. Treatment is mainly supportive and immunotherapy is given to shorten the disease course. Aims: The aim of this study was to define the outcome of GBS with plasmapheresis and to determine its clinical spectrum. Materials and Methods: The prospective study was done at Mayo Hospital, Lahore, for 1 year from November 2020 to November 2021. The diagnosis of GBS was made on Brighton criteria for GBS. The outcome of therapy was assessed at 3 and 6 months, using the Medical Research Council Scale and Hughes Functional Grading Scale (HFGS). Results: A total of 50 patients were enrolled in the study. Twenty-seven (54%) were males and 23 (46%) were females. Seventeen (34%) had acute motor axonal neuropathy, 16 (32%) had acute motor and sensory axonal neuropathy, 15 (30%) had acute inflammatory demyelinating polyradiculoneuropathy, and 2 (4%) had Miller-Fisher syndrome. Plasmapheresis was done in all patients. HFGS score was assessed at discharge, at 3 months, and after 6 months of illness onset. The improvement in mean HFGS score was 2.79 ± 0.41 at 3 months and 1.94 ± 0.25 at 6 months of symptoms onset from the mean score of 3.46 ± 0.93 at the time of discharge from the hospital. Conclusion: Excellent outcome was observed after plasmapheresis. Majority of participants were able to walk without support at the 6-month follow-up. Plasmapheresis should be initiated early in the management of GBS where intravenous immunoglobulins are costly.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48040260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Large cell neuroendocrine carcinoma of the lung in posttuberculosis cavity 肺结核后腔的大细胞神经内分泌癌
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_23_22
M. Abdulla
A 73-year-old male was admitted with hemoptysis for 2 months. He was diagnosed to have sputum-positive pulmonary tuberculosis 4 years back and was treated with antitubercular drugs for 6 months. Contrast-enhanced computed tomography (CT) of the thorax at that time revealed a cavitary lesion with surrounding consolidation in the right lower lobe of the lung. Contrast-enhanced CT of the chest during present admission showed a mass lesion in the lower lobe of the right lung, which was diagnosed as large cell neuroendocrine carcinoma of the lung on histopathological examination. We describe a patient who developed large cell neuroendocrine carcinoma of the lung in a posttuberculosis cavity which, to our knowledge, is the first such report.
一名73岁男性因咳血入院2个月。4年前,他被诊断为痰阳性肺结核,并接受了6个月的抗结核药物治疗。当时胸部的对比增强计算机断层扫描(CT)显示右肺下叶有空洞性病变,周围有实变。本次入院期间胸部增强CT显示右肺下叶有肿块,组织病理学检查诊断为肺大细胞神经内分泌癌。我们描述了一名在结核后腔中发展为肺大细胞神经内分泌癌的患者,据我们所知,这是第一例此类报告。
{"title":"Large cell neuroendocrine carcinoma of the lung in posttuberculosis cavity","authors":"M. Abdulla","doi":"10.4103/injms.injms_23_22","DOIUrl":"https://doi.org/10.4103/injms.injms_23_22","url":null,"abstract":"A 73-year-old male was admitted with hemoptysis for 2 months. He was diagnosed to have sputum-positive pulmonary tuberculosis 4 years back and was treated with antitubercular drugs for 6 months. Contrast-enhanced computed tomography (CT) of the thorax at that time revealed a cavitary lesion with surrounding consolidation in the right lower lobe of the lung. Contrast-enhanced CT of the chest during present admission showed a mass lesion in the lower lobe of the right lung, which was diagnosed as large cell neuroendocrine carcinoma of the lung on histopathological examination. We describe a patient who developed large cell neuroendocrine carcinoma of the lung in a posttuberculosis cavity which, to our knowledge, is the first such report.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47479038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the fight against COVID-19 falling prey to vaccine hesitancy? 抗击新冠肺炎的斗争是否成为疫苗犹豫的牺牲品?
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_131_22
A. Prakash, Ramesh Aggarwal
{"title":"Is the fight against COVID-19 falling prey to vaccine hesitancy?","authors":"A. Prakash, Ramesh Aggarwal","doi":"10.4103/injms.injms_131_22","DOIUrl":"https://doi.org/10.4103/injms.injms_131_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46473261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A paraneoplastic optic neuropathy revealing a pulmonary epidermal carcinoma 副肿瘤性视神经病变显示肺表皮癌
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_42_22
Y. Mouzari, I. Fiqhi, Belfaiza Soukaina, T. Abdellaoui, M. Allaoui, K. Reda, A. Oubaaz
Paraneoplastic optic neuropathy is a relatively rare ocular manifestation. We report the case of a patient with bilateral papilledema revealing a pulmonary squamous cell carcinoma. Paraneoplastic neuropathy is linked to an immune reaction by the presence of autoantibodies against collapsin responsive mediator protein 5 . Diagnosis is based on the determination of these autoantibodies and the search for occult cancer by PET scan.Treatment is often based on corticosteroid therapy and sometimes immunosuppressive treatment is necessary in the case of corticosteroid unresponsiveness.
副肿瘤性视神经病变是一种相对罕见的眼部表现。我们报告了一例双侧视乳头水肿的患者,显示为肺鳞状细胞癌。副肿瘤性神经病与免疫反应有关,这是由于存在抗组织蛋白酶反应介质蛋白5的自身抗体。诊断是基于这些自身抗体的测定和通过PET扫描寻找隐性癌症。治疗通常基于皮质类固醇治疗,有时在皮质类固醇无反应的情况下需要免疫抑制治疗。
{"title":"A paraneoplastic optic neuropathy revealing a pulmonary epidermal carcinoma","authors":"Y. Mouzari, I. Fiqhi, Belfaiza Soukaina, T. Abdellaoui, M. Allaoui, K. Reda, A. Oubaaz","doi":"10.4103/injms.injms_42_22","DOIUrl":"https://doi.org/10.4103/injms.injms_42_22","url":null,"abstract":"Paraneoplastic optic neuropathy is a relatively rare ocular manifestation. We report the case of a patient with bilateral papilledema revealing a pulmonary squamous cell carcinoma. Paraneoplastic neuropathy is linked to an immune reaction by the presence of autoantibodies against collapsin responsive mediator protein 5 . Diagnosis is based on the determination of these autoantibodies and the search for occult cancer by PET scan.Treatment is often based on corticosteroid therapy and sometimes immunosuppressive treatment is necessary in the case of corticosteroid unresponsiveness.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45001016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of reference management software among Allopathy, Ayurveda, and Homeopathy practices 在对抗疗法、阿育吠陀和顺势疗法实践中使用参考管理软件
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_95_22
Ellora Barman, B. Barman, A. Nune, A. Nongpiur
Background: Reference management software (RMS) enable researchers to organize and manage large number of references that are typically identified during the publication of research articles. Aims and Objectives: The purpose of our study was to determine the extent to which faculties from allopathy, homeopathy, and Ayurveda use RMS for their academic pursuits and to identify which methods are used most frequently. Methods: The survey was circulated among the faculties of three different disciplines of the health-care system to collect respondent demographic details and questionnaire responses. Data distribution and variable type were used to perform descriptive analysis. Results: The data from 114/150 respondents were analyzed. Of the 114 faculties who responded to our survey, 72 (63%) reported using RMS to publish their articles. Knowledge of how to use RMS software is common in allopathic faculties (40%), followed by homeopathy (14%) and Ayurveda (9%). Zotero (41%) is the most popular RMS software among users, followed by Mendeley (31%) and Endnote (12%). Conclusion: Despite being underreported, RMS software is frequently used for the needs of authors from various disciplines in the health-care system.
背景:参考文献管理软件(RMS)使研究人员能够组织和管理在研究论文发表期间通常识别的大量参考文献。目的和目的:我们研究的目的是确定对抗疗法、顺势疗法和阿育吠陀的院系在学术追求中使用RMS的程度,并确定哪种方法使用最频繁。方法:在卫生保健系统三个不同学科的院系中进行调查,收集调查对象的人口统计资料和问卷回答。采用数据分布和变量类型进行描述性分析。结果:对114/150名受访者的数据进行了分析。在114个回应我们调查的院系中,72个(63%)表示使用RMS发表他们的文章。了解如何使用RMS软件在对抗疗法院系中很常见(40%),其次是顺势疗法(14%)和阿育吠陀(9%)。Zotero(41%)是用户中最受欢迎的RMS软件,其次是Mendeley(31%)和Endnote(12%)。结论:尽管被低估,RMS软件经常用于满足卫生保健系统中不同学科作者的需求。
{"title":"Use of reference management software among Allopathy, Ayurveda, and Homeopathy practices","authors":"Ellora Barman, B. Barman, A. Nune, A. Nongpiur","doi":"10.4103/injms.injms_95_22","DOIUrl":"https://doi.org/10.4103/injms.injms_95_22","url":null,"abstract":"Background: Reference management software (RMS) enable researchers to organize and manage large number of references that are typically identified during the publication of research articles. Aims and Objectives: The purpose of our study was to determine the extent to which faculties from allopathy, homeopathy, and Ayurveda use RMS for their academic pursuits and to identify which methods are used most frequently. Methods: The survey was circulated among the faculties of three different disciplines of the health-care system to collect respondent demographic details and questionnaire responses. Data distribution and variable type were used to perform descriptive analysis. Results: The data from 114/150 respondents were analyzed. Of the 114 faculties who responded to our survey, 72 (63%) reported using RMS to publish their articles. Knowledge of how to use RMS software is common in allopathic faculties (40%), followed by homeopathy (14%) and Ayurveda (9%). Zotero (41%) is the most popular RMS software among users, followed by Mendeley (31%) and Endnote (12%). Conclusion: Despite being underreported, RMS software is frequently used for the needs of authors from various disciplines in the health-care system.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44103884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine ChAdOx1-nCoV-19疫苗接种后的皮肤白细胞破裂性血管炎
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_87_22
M. Abdulla
{"title":"Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine","authors":"M. Abdulla","doi":"10.4103/injms.injms_87_22","DOIUrl":"https://doi.org/10.4103/injms.injms_87_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43437473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Exudative retinal detachment: An unusual ocular manifestation of syphilis 渗出性视网膜脱离:梅毒的一种不寻常的眼部表现
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_62_22
Belfaiza Soukaina, Abdellaoui Taoufiq, Fiqhi Issam, Mouzari Yassine, R. Karim, Oubaaz Bar
Ocular syphilis is a disease known as a great simulator.It can affect the structures of the eye. It often manifests by an anterior uveitis. Posterior segment involvement is very rare and it is exceptionally complicated by exudative retinal detachment. We report the case of a patient with bilateral bullous retinal detachment in the context of ocular syphilis with a good evolution after treatment by penicillin G and corticotherapy.
眼梅毒是一种被称为伟大模拟器的疾病。它会影响眼睛的结构。它通常表现为前葡萄膜炎。后段受累非常罕见,渗出性视网膜脱离异常复杂。我们报告了一例患有双侧大疱性视网膜脱离的眼梅毒患者,经青霉素G和皮质类固醇治疗后进展良好。
{"title":"Exudative retinal detachment: An unusual ocular manifestation of syphilis","authors":"Belfaiza Soukaina, Abdellaoui Taoufiq, Fiqhi Issam, Mouzari Yassine, R. Karim, Oubaaz Bar","doi":"10.4103/injms.injms_62_22","DOIUrl":"https://doi.org/10.4103/injms.injms_62_22","url":null,"abstract":"Ocular syphilis is a disease known as a great simulator.It can affect the structures of the eye. It often manifests by an anterior uveitis. Posterior segment involvement is very rare and it is exceptionally complicated by exudative retinal detachment. We report the case of a patient with bilateral bullous retinal detachment in the context of ocular syphilis with a good evolution after treatment by penicillin G and corticotherapy.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48243988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Naltrexone beyond psychiatric domain 纳曲酮超出了精神病学领域
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_35_22
Ashutosh Garg, Khyati Thapliyal, Vivek Singh
Naltrexone, an opioid receptor (OR) antagonist, at its standard doses, is a United States Federal Drug Administration-approved drug for opioid and alcohol use disorders. However, with the discovery of nonneuropsychiatric effects of OR signaling with low-dose naltrexone, it has found novel applications in inflammatory, malignant, insulin sensitivity-related, and chronic pain conditions. Lower doses also ameliorate its adverse effects. Its off-label use in the abovementioned situations has proven to be cost-effective against costly immunomodulating and antineoplastic drugs. Its lower cost and miniscule margin of interest have precluded in-depth analysis by the pharmaceutical industry. So far, only animal studies, cell culture studies, and case reports have been conducted, some of which exhibit promising benefits. There is a dearth of much-needed quality trials.
纳曲酮是一种阿片受体(OR)拮抗剂,标准剂量,是美国联邦药品管理局批准的治疗阿片类药物和酒精使用障碍的药物。然而,随着低剂量纳曲酮OR信号的非神经精神作用的发现,它在炎症、恶性、胰岛素敏感性相关和慢性疼痛条件下有了新的应用。较低的剂量也能减轻其不良影响。它在上述情况下的标示外使用已被证明对昂贵的免疫调节和抗肿瘤药物具有成本效益。其较低的成本和极小的利润率阻碍了制药行业的深入分析。到目前为止,只进行了动物研究、细胞培养研究和病例报告,其中一些研究显示出了有希望的益处。缺乏急需的高质量试验。
{"title":"Naltrexone beyond psychiatric domain","authors":"Ashutosh Garg, Khyati Thapliyal, Vivek Singh","doi":"10.4103/injms.injms_35_22","DOIUrl":"https://doi.org/10.4103/injms.injms_35_22","url":null,"abstract":"Naltrexone, an opioid receptor (OR) antagonist, at its standard doses, is a United States Federal Drug Administration-approved drug for opioid and alcohol use disorders. However, with the discovery of nonneuropsychiatric effects of OR signaling with low-dose naltrexone, it has found novel applications in inflammatory, malignant, insulin sensitivity-related, and chronic pain conditions. Lower doses also ameliorate its adverse effects. Its off-label use in the abovementioned situations has proven to be cost-effective against costly immunomodulating and antineoplastic drugs. Its lower cost and miniscule margin of interest have precluded in-depth analysis by the pharmaceutical industry. So far, only animal studies, cell culture studies, and case reports have been conducted, some of which exhibit promising benefits. There is a dearth of much-needed quality trials.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43397396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The posterior fossa intracranial pressure monitoring in neurocritical care: It is time to evaluate objectively in forbidden territories 后窝颅内压监测在神经危重症监护中的应用:是时候客观评价禁区了
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_72_22
Tariq Janjua, L. Moscote-Salazar, W. Florez-Perdomo
{"title":"The posterior fossa intracranial pressure monitoring in neurocritical care: It is time to evaluate objectively in forbidden territories","authors":"Tariq Janjua, L. Moscote-Salazar, W. Florez-Perdomo","doi":"10.4103/injms.injms_72_22","DOIUrl":"https://doi.org/10.4103/injms.injms_72_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42468207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute hemorrhagic leukoencephalitis in COVID-19 infection COVID-19感染的急性出血性白脑炎
IF 0.6 Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_71_22
M. Abdulla
{"title":"Acute hemorrhagic leukoencephalitis in COVID-19 infection","authors":"M. Abdulla","doi":"10.4103/injms.injms_71_22","DOIUrl":"https://doi.org/10.4103/injms.injms_71_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46060221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Specialities
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1